Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
189.19B | 208.35B | 241.39B | 157.74B | 105.94B | Gross Profit |
30.24B | 64.06B | 55.10B | 22.86B | 10.18B | EBIT |
14.84B | 46.98B | 44.76B | 15.09B | -346.00M | EBITDA |
28.85B | 43.50B | 29.43B | 28.37B | -7.03B | Net Income Common Stockholders |
381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
39.37B | 28.59B | 29.77B | 30.96B | 29.53B | Total Assets |
282.23B | 280.29B | 288.12B | 287.27B | 267.65B | Total Debt |
71.55B | 63.08B | 55.49B | 69.79B | 81.93B | Net Debt |
32.34B | 35.33B | 26.30B | 39.11B | 52.73B | Total Liabilities |
203.91B | 194.80B | 205.13B | 196.83B | 182.09B | Stockholders Equity |
59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | Free Cash Flow | |||
12.00B | 17.75B | 28.86B | 12.72B | -144.00M | Operating Cash Flow |
27.30B | 32.04B | 40.93B | 23.61B | 12.16B | Investing Cash Flow |
-13.25B | -14.87B | -13.71B | -5.69B | -7.86B | Financing Cash Flow |
-7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $115.32B | 11.61 | 16.16% | 3.44% | -2.57% | -14.01% | |
76 Outperform | $277.42B | 16.08 | 11.28% | 4.22% | -1.90% | -14.56% | |
75 Outperform | $45.70B | 16.41 | 27.41% | 1.27% | 20.51% | 99.86% | |
73 Outperform | $485.12B | 13.91 | 14.38% | 3.56% | 1.86% | -11.52% | |
72 Outperform | $44.48B | 19.33 | 8.88% | 1.86% | -4.35% | -37.69% | |
61 Neutral | $85.79B | 224.58 | 0.59% | 5.79% | -9.97% | -98.08% | |
57 Neutral | $8.34B | 5.35 | -5.98% | 7.29% | 0.20% | -69.45% |